Large scale evidence and replication: Insights from rheumatology and beyond

Annals of the Rheumatic Diseases

Volumn 64, Issue 3, 2005, Pages 345-346

  Ioannidis, J P A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; MEDICAL RESEARCH; METHODOLOGY; POPULATION RISK; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SHORT SURVEY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY; SAMPLE SIZE;

EID: 14144249848     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.027979     Document Type: Short Survey

References (20)

1. Kyriakidi M, Ioannidis JP. Design and quality considerations for randomized controlled trials in systemic sclerosis. Arthritis Rheum 2002;47:73-81.
2. Karassa FB, Tatsioni A, Ioannidis JP. Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus. J Rheumatol 2003;30:979-84.
3. Hill CL, LaValley MP, Felson DT. Secular changes in the quality of published randomized clinical trials in rheumatology. Arthritis Rheum 2002;46:779-84.
4. Ioannidis JP. Genetic associations: false or true? Trends Mol Med 2003;9:135-8.
5. Ntzani EE, Ioannidis JP. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet 2003;362:1439-44.
6. Ransohoff DF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer 2004;4:309-14.
7. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.
8. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
9. Huizinga TWJ, Pisetsky DS, Kimberly RP. Associations, populations, and the truth: recommendations for genetic association studies in Arthritis and Rheumatism. Arthritis Rheum 2004;50:2066-71.
10. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
11. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002;46:741-7.
12. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308.
13. Cervera R, Piette JC, Font J, Khamashto MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-27.
14. Ioannidis JPA, Vlachoyiannopoulos PG, Haidich A-B, Medsger TA Jr, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med (in press).
15. Wolfe F, Lassere M, van der Heijde D, Stucki G, Suarez-Almazor M, Pincus T, et al. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 1999;26:484-9.
16. Olkin I. Meta-analysis: reconciling the results of independent studies. Stat Med 1995;14:457-72.
17. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987;316:450-5.
18. Lau J, Ioannidis JP, Schmid CH. Summing up evidence: one answer is not always enough. Lancet 1998;351:123-7.
19. Gotzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Control Clin Trials 1989;10:31-56.
20. Gotzsche PC. Reporting of outcomes in arthritis trials measured on ordinal and interval scales is inadequate in relation to meta-analysis. Ann Rheum Dis 2001;60:349-52.